Asia Pacific: In Asia Pacific, countries like China, Japan, and South Korea are witnessing a surge in the demand for DNA repair drugs. Factors such as growing geriatric population, rising government initiatives for cancer research, and increasing awareness about genomic medicine are contributing to the market growth in the region.
Europe: The DNA Repair Drugs market in Europe is also displaying a positive growth trajectory, with countries like the United Kingdom, Germany, and France leading the way. High healthcare expenditure, robust healthcare infrastructure, and increasing R&D activities in the pharmaceutical sector are expected to drive market growth in the region.